• Accueil >
  • Publications >
  • AsiDNA Treatment Induces Cumulative Antitumor Efficacy with a Low Probability of Acquired Resistance

AsiDNA Treatment Induces Cumulative Antitumor Efficacy with a Low Probability of Acquired Resistance

1 sept. 2019Neoplasia

DOI : 10.1016/j.neo.2019.06.006

Auteurs

Wael Jdey, Maria Kozlak, Sergey Alekseev, Sylvain Thierry, Pauline Lascaux, Pierre-Marie Girard, Françoise Bono, Marie Dutreix

Membres

PIERRE-MARIE GIRARD

Chargé de recherche CNRS